Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists

Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists

US Patent 6506756 · Granted Jan 14, 2003

Estimated economic value: $151,779,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PAPD5 inhibitors and methods of use thereof2025
Methods and formulations to treat mitochondrial dysfunction2025
Re-identifying pseudonymized or de-identified data utilizing distributed ledger 2025
Substituted heterocycles as aldehyde dehydrogenase inhibitors2024
PGDH inhibitors and methods of making and using2024
SREBP inhibitors comprising a 6-membered central ring2023
Derivatives of piperlongumine and uses thereof2022
PGDH inhibitors and methods of making and using2022
Adrenergic receptor modulating compounds and methods of using the same2021
Compounds and their use for reducing uric acid levels2021
Compounds and their use for reducing uric acid levels2021
Compounds and their use for reducing uric acid levels2021